-
New cancer drugs approvals underpinned by flawed evidence
europeanpharmaceuticalreview
September 20, 2019
A new report has shown that trial evidence alone is not enough when approving new cancer drugs and that an assessment of that evidence is also needed.
-
House Speaker Unveils Plan to Lower Drug Costs
drugs
September 20, 2019
House Speaker Nancy Pelosi has revealed a plan to lower the cost of medications for people on Medicare and those with private insurance.
-
Multiple myeloma treatment granted Orphan Drug Designation
europeanpharmaceuticalreview
September 19, 2019
Orphan Drug Designation has been given to bispecific antibody candidate, GBR 1342, for the treatment of multiple myeloma.
-
Collaborative oncology drugs review initiative announced by FDA
europeanpharmaceuticalreview
September 19, 2019
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
-
2002 to 2016 Saw Rise in Drug Abuse-Linked Infective Endocarditis
drugs
September 19, 2019
According to a study published online Sept. 18 in the Journal of the American Heart Association, the incidence of infective endocarditis (IE) associated with drug abuse (DA) increased from 2002 to 2016 ...
-
Glenmark Receives Orphan Drug Designation for Multiple Myeloma Candidate
americanpharmaceuticalreview
September 18, 2019
Glenmark announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma ...
-
FDA takes first action under new international collaboration with Australia and Canada
worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
-
Off-Label Ordering of Systemic Drugs Up for Children
drugs
September 18, 2019
The rate of off-label ordering of systemic drugs has increased for children, according to a study published online Sept. 16 in Pediatrics.
-
Gene-targeted cancer drugs, slow release overcome resistance
worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...
-
FDA grants Orphan Drug Designation to sotatercept
europeanpharmaceuticalreview
September 16, 2019
Orphan Drug Designation has been given to sotatercept for the treatment of patients with pulmonary arterial hypertension.